Ventilator-associated pneumonia (VAP) is one of the most frequent ICU-acquired infections.
Reported incidences vary widely from 5 to 40% depending on the setting and diagnostic …

Ventilator-associated pneumonia (VAP) continues to complicate the course of 8 to 28% of
patients receiving mechanical ventilation (MV). In contrast to infections of more frequently …

EXECUTIVE SUMMARY Since the initial 1996 American Thoracic Society (ATS) guideline
on nosocomial pneumonia, a number of new developments have appeared, mandating a …

Background: Understanding the risk factors for ventilator-associated pneumonia can help to
assess prognosis and devise and test preventive strategies. Objective: To examine the …

Background: Ventilator-associated pneumonia (VAP) is the most common nosocomial
infection in critically ill patients. The clinical and economic consequences of VAP are …

While critically ill patients experience a life-threatening illness, they commonly contract
ventilator-associated pneumonia. This nosocomial infection increases morbidity and likely …

Background: Health care–associated infections from invasive medical devices in the
intensive care unit (ICU) are a major threat to patient safety. Most published studies of ICU …

Background This is an update of a review last published in Issue 5, 2010, of The Cochrane
Library. Reducing weaning time is desirable in minimizing potential complications from …

To evaluate the attributable morbidity and mortality of ventilator-associated pneumonia
(VAP) in intensive care unit (ICU) patients, we conducted a prospective, matched cohort …

Objective To determine the attributable cost of ventilator-associated pneumonia from a
hospital-based cost perspective, after adjusting for potential confounders. Design Patients …